Anela Kellogg
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
-
- HIV-related health complications and treatments
Papers in
-
- HIV/AIDS drug development and treatment 2
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 2
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Colleen M. Hadigan (4 shared papers)Raul M. Alfaro (3 shared papers)Kristina M. Brooks (3 shared papers)Jomy M. George (3 shared papers)Parag Kumar (3 shared papers)Adam W. Rupert (3 shared papers)Jay Nelson Lozier (2 shared papers)Scott R Penzak (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Clinical Infectious Diseases (2 papers)Journal of Hospice and Palliative Nursing (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Palliative & Supportive Care (1 paper)
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Anela Kellogg
10 papers receiving 337 citations
Peers
Comparison fields: 5 of 62
- Infectious Diseases 142
- Emergency Medicine 33
- Virology 12
- Hepatology 19
- Neurology 34
Countries citing papers authored by Anela Kellogg
This map shows the geographic impact of Anela Kellogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anela Kellogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anela Kellogg more than expected).
Fields of papers citing papers by Anela Kellogg
This network shows the impact of papers produced by Anela Kellogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anela Kellogg. The network helps show where Anela Kellogg may publish in the future.
Co-authors
The 25 scholars most cited alongside Anela Kellogg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 73 | |
| 2 | 2019 | 71 | |
| 3 | 2018 | 48 | |
| 4 | 2017 | 47 | |
| 5 | 2022 | 36 | |
| 6 | 2016 | 21 | |
| 7 | 2016 | 15 | |
| 8 | 2022 | 15 | |
| 9 | 2016 | 12 | |
| 10 | 2021 | 10 |
About Anela Kellogg
Anela Kellogg is a scholar working on Infectious Diseases, Neurology, Cardiology and Cardiovascular Medicine, Health and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 348 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (2 papers), HIV/AIDS drug development and treatment (2 papers), COVID-19 Clinical Research Studies (2 papers), Palliative Care and End-of-Life Issues (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), HIV-related health complications and treatments (1 paper), Inflammasome and immune disorders (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (142 citations), Emergency Medicine (33 citations), Virology (12 citations), Hepatology (19 citations) and Neurology (34 citations). Anela Kellogg has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include Colleen M. Hadigan, Raul M. Alfaro, Kristina M. Brooks, Jomy M. George, Parag Kumar, Adam W. Rupert, Jay Nelson Lozier, Scott R Penzak, Khanh Nghiem and Princy N. Kumar. Their work appears in journals such as Frontiers in Immunology, Clinical Infectious Diseases, Journal of Hospice and Palliative Nursing, Antimicrobial Agents and Chemotherapy and Palliative & Supportive Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.